LITFULO
Identification of Litfulo
| No description |
Google image searchProduct monograph
Active ingredient
ritlecitinib (ritlecitinib tosylate), 50 MG
DIN: 02543532
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 13-FEB-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
- L04AF08 — RITLECITINIB (ATC/DDD)
